Cellbyte GmbH

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Cellbyte GmbH - overview

Established

2024

Location

Munich, -, Germany

Primary Industry

Healthcare IT

About

Based in Germany, Cellbyte GmbH specializes in providing innovative market intelligence and pricing solutions for the pharmaceutical industry, enhancing decision-making for professionals globally. Cellbyte GmbH, founded in 2024 in Munich, Germany, focuses on delivering critical market intelligence tools for the pharmaceutical sector. The company recently raised USD 2. 75 mn in SEED funding on November 4, 2025, led by Frontline, with contributions from Y Combinator, Pace Ventures Enigma, Saras Capital, Soma Capital Management, and Springboard Health Angels.


The total amount raised by the company is USD 2. 75 mn, indicating a concentrated investment focus on enhancing its operational capabilities. Cellbyte offers a comprehensive platform designed to streamline access to critical pricing and market intelligence for the pharmaceutical industry. The core product integrates multiple functionalities, enabling professionals to swiftly extract insights from over 100 trusted data sources related to global regulations, health technology assessments, pricing, and access strategies.


This platform serves pricing and market access professionals across various pharmaceutical firms, facilitating tasks such as disease landscape analyses and real-time tracking of market changes globally, including key regions like North America, Europe, and Asia. Cellbyte's revenue model is structured around subscriptions and partnerships, providing clients access to a suite of tools that enhance their market access capabilities. The company offers tiered subscription plans based on clients' needs for data integration, document intelligence, and analytics, thus ensuring continuous access to features like the Cellbyte Data Vault for secure information storage and sharing, alongside real-time updates on market dynamics. In November 2025, Cellbyte GmbH secured USD 2.


75 mn in Seed funding, which will be utilized to enhance its engineering capabilities and support workforce expansion. The company is focused on launching new products that will further integrate advanced functionalities into its platform. Additionally, Cellbyte aims to expand its market presence in North America, Europe, and Asia, with strategic plans to penetrate additional regions by 2026.


Current Investors

Y Combinator, Frontline, Soma Capital Management

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Pharmaceuticals, Medical Software

Website

www.cellbyte.com

Verticals

Artificial Intelligence, Cloud Computing, HealthTech, RegTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.